Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BIRC7 Antikörper (Middle Region)

BIRC7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN926876
  • Target Alle BIRC7 Antikörper anzeigen
    BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
    Bindungsspezifität
    • 15
    • 8
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reaktivität
    • 56
    • 15
    • 15
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 49
    • 6
    • 1
    Kaninchen
    Klonalität
    • 50
    • 6
    Polyklonal
    Konjugat
    • 32
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BIRC7 Antikörper ist unkonjugiert
    Applikation
    • 49
    • 20
    • 15
    • 13
    • 13
    • 12
    • 10
    • 6
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    Purified
    Immunogen
    BIRC7 antibody was raised in rabbit using the middle region of BIRC7 as the immunogen
    Top Product
    Discover our top product BIRC7 Primärantikörper
  • Applikationshinweise
    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    BIRC7 Blocking Peptide, catalog no. 33R-2387, is also available for use as a blocking control in assays to test for specificity of this BIRC7 antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Konzentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Target
    BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
    Andere Bezeichnung
    BIRC7 (BIRC7 Produkte)
    Synonyme
    KIAP antikoerper, LIVIN antikoerper, ML-IAP antikoerper, MLIAP antikoerper, RNF50 antikoerper, EIAP/XLX antikoerper, XLX antikoerper, kiap antikoerper, livin antikoerper, ml-iap antikoerper, mliap antikoerper, rnf50 antikoerper, xEIAP antikoerper, RGD1562883 antikoerper, zgc:165605 antikoerper, E130019N06 antikoerper, Livin antikoerper, birc7 antikoerper, bird7a antikoerper, xEIAP/XLX antikoerper, xlx antikoerper, EIAP/XLX-B antikoerper, birc7b antikoerper, baculoviral IAP repeat containing 7 antikoerper, baculoviral IAP repeat-containing 7 antikoerper, baculoviral IAP repeat-containing 7 (livin) antikoerper, baculoviral IAP repeat containing 7 S homeolog antikoerper, baculoviral IAP repeat containing 7 L homeolog antikoerper, BIRC7 antikoerper, birc7 antikoerper, Birc7 antikoerper, birc7.S antikoerper, birc7.L antikoerper
    Hintergrund
    BIRC7 protects against apoptosis induced by TNF or by chemical agents such as adriamycin, etoposide or staurosporine. Suppression of apoptosis is mediated by activation of MAPK8/JNK1, and possibly also of MAPK9/JNK2. This activation depends on TAB1 and NR2C2/TAK1. In vitro, inhibits caspase-3 and proteolytic activation of pro-caspase-9. Isoform 1 blocks staurosporine-induced apoptosis. Isoform 2 blocks etoposide-induced apoptosis. Synonyms: Polyclonal BIRC7 antibody, Anti-BIRC7 antibody, baculoviral IAP repeat-containing 7, livin antibody, KIAP antibody, LIVIN antibody, ML-IAP antibody, MLIAP antibody, RNF50 antibody.
Sie sind hier:
Kundenservice